Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation

BACKGROUND: Shenmai injection (SMI) has been used in the treatment of cardiovascular disease (CVD), such as heart failure, myocardial ischemia and coronary heart disease. It has been found to have efficacy on doxorubicin (DOX)-induced cardiomyopathy. The aims of this study were to explore the underl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Complement Med Ther
Principais autores: Li, Lin, Yang, Dongli, Li, Jinghao, Niu, Lu, Chen, Ye, Zhao, Xin, Oduro, Patrick Kwabena, Wei, Chun, Xu, Zongpei, Wang, Qilong, Li, Yuhong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158159/
https://ncbi.nlm.nih.gov/pubmed/32293408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-020-02905-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados